[go: up one dir, main page]

AU2001261007A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents

Compositions and methods for the therapy and diagnosis of lung cancer

Info

Publication number
AU2001261007A1
AU2001261007A1 AU2001261007A AU6100701A AU2001261007A1 AU 2001261007 A1 AU2001261007 A1 AU 2001261007A1 AU 2001261007 A AU2001261007 A AU 2001261007A AU 6100701 A AU6100701 A AU 6100701A AU 2001261007 A1 AU2001261007 A1 AU 2001261007A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261007A
Inventor
Paul A. Algate
Darin R. Benson
Mark Elliot
Steven P. Fling
Robert A. Henderson
Carol Yoseph Indirias
Michael D. Kalos
Michael J. Lodes
Jane Mannion
Raodoh Mohamath
Steven G Reed
Heather Secrist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/738,973 external-priority patent/US20020110563A1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001261007A1 publication Critical patent/AU2001261007A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001261007A 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer Abandoned AU2001261007A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US53803700A 2000-03-29 2000-03-29
US09/538,037 2000-03-29
US58893700A 2000-06-05 2000-06-05
US09/588,937 2000-06-05
US64087800A 2000-08-18 2000-08-18
US09/640,878 2000-08-18
US23451700P 2000-09-22 2000-09-22
US60/234,517 2000-09-22
US70451200A 2000-11-01 2000-11-01
US09/704,512 2000-11-01
US09/738,973 US20020110563A1 (en) 2000-11-01 2000-12-14 Compositions and methods for the therapy and diagnosis of lung cancer
US09/738,973 2000-12-14
PCT/US2001/009991 WO2001072295A2 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
AU2001261007A1 true AU2001261007A1 (en) 2001-10-08

Family

ID=27559252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261007A Abandoned AU2001261007A1 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Country Status (7)

Country Link
JP (1) JP2004526401A (en)
AU (1) AU2001261007A1 (en)
CA (1) CA2404233A1 (en)
CZ (1) CZ20023567A3 (en)
HU (1) HUP0500345A2 (en)
PL (1) PL366626A1 (en)
WO (1) WO2001072295A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082212A1 (en) * 2000-07-20 2002-06-27 Millennium Pharmaceuticals, Inc. 7716, a novel human ATPase and uses therefor
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
AU2002311909A1 (en) * 2001-05-11 2002-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
US7718787B2 (en) * 2002-10-18 2010-05-18 Lg Life Sciences Limited Gene families associated with cancers
DE10258051A1 (en) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Use of substances that bind to HAT for the diagnosis and treatment of squamous cell carcinoma of the lungs
AU2003295189A1 (en) * 2002-12-17 2004-07-09 Fondazione Centro San Raffaele Del Monte Tabor Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof
US20060241051A1 (en) 2002-12-26 2006-10-26 Chieko Kitada Metastin derivatives and use thereof
JP4346650B2 (en) 2004-06-25 2009-10-21 武田薬品工業株式会社 Metastin derivatives and uses thereof
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
TWI386417B (en) 2005-12-22 2013-02-21 Takeda Pharmaceutical Metastin derivatives and use thereof
JP2007263896A (en) * 2006-03-29 2007-10-11 Univ Nagoya Biomarker and method for predicting postoperative prognosis of lung cancer patients
TWI404726B (en) 2006-10-25 2013-08-11 Takeda Pharmaceutical Metastin derivatives and use thereof
JP5648261B2 (en) * 2006-12-20 2015-01-07 東レ株式会社 Cancer detection method
US9416192B2 (en) 2008-08-05 2016-08-16 Toray Industries, Inc. Pharmaceutical composition for treatment and prevention of cancers
PL2733492T3 (en) * 2008-08-05 2016-08-31 Toray Industries Method of cancer detection
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
RU2532105C2 (en) 2008-10-22 2014-10-27 Онкотерапи Сайенс, Инк. Epitopic peptides rab6kifl/kif20a and vaccines containing them
MX340014B (en) 2010-02-04 2016-06-22 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer.
RU2603742C2 (en) 2010-02-04 2016-11-27 Торэй Индастриз, Инк. Pharmaceutical composition for treatment and/or prevention of cancer
JP5923985B2 (en) 2010-02-04 2016-05-25 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
EP2532367B1 (en) 2010-02-04 2018-08-29 Toray Industries, Inc. Pharmaceutical agent for treatment and/or prevention of cancer
CN102821789B (en) 2010-02-04 2016-03-02 东丽株式会社 Cancer treat and/or prevent pharmaceutical composition
BR112012019098B8 (en) 2010-02-04 2021-08-17 Toray Industries antibody, pharmaceutical composition, pharmaceutical combination and uses of an antibody, a pharmaceutical composition and a pharmaceutical combination
DK2740794T3 (en) 2011-08-04 2018-06-14 Toray Industries PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR CANCER PREVENTION
JP6094220B2 (en) 2011-08-04 2017-03-15 東レ株式会社 Method for detecting pancreatic cancer
PL2740798T3 (en) 2011-08-04 2017-07-31 Toray Industries, Inc. Cancer treatment and/or prevention drug composition
JP6065591B2 (en) 2011-08-04 2017-01-25 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
HUE033149T2 (en) 2011-08-04 2017-11-28 Toray Industries Pharmaceutical composition for treatment and/or prophylaxis of cancer
KR102041832B1 (en) 2011-08-04 2019-11-08 도레이 카부시키가이샤 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
WO2013018892A1 (en) 2011-08-04 2013-02-07 東レ株式会社 Drug composition for cancer treatment and/or prevention
JP6187255B2 (en) 2012-02-21 2017-08-30 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
KR102009236B1 (en) 2012-02-21 2019-08-09 도레이 카부시키가이샤 Pharmaceutical composition for treatment and/or prevention of cancer
DK2818483T3 (en) 2012-02-21 2017-10-23 Toray Industries Medical composition for the treatment and / or prevention of cancer
WO2013125630A1 (en) 2012-02-21 2013-08-29 東レ株式会社 Pharmaceutical composition for treatment and/or prevention of cancer
ES2656620T3 (en) 2012-03-30 2018-02-27 Toray Industries, Inc. Pharmaceutical composition for the treatment and / or prevention of liver cancer
HUE036425T2 (en) 2012-03-30 2018-07-30 Toray Industries Pharmaceutical composition for treatment and/or prevention of gallbladder cancer
PL2876446T3 (en) 2012-07-19 2019-06-28 Toray Industries, Inc. HOW TO DETECT THE CANCER
AU2013291051C1 (en) 2012-07-19 2019-07-04 Toray Industries, Inc. Cancer detection method
EP3031826B1 (en) 2013-08-09 2018-10-10 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1187915A2 (en) * 1999-04-02 2002-03-20 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001079292A2 (en) * 2000-04-17 2001-10-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
WO2001083553A2 (en) * 2000-05-03 2001-11-08 Pharmacia & Upjohn Company G protein-coupled receptors
WO2001096390A2 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
WO2001072295A3 (en) 2002-08-22
PL366626A1 (en) 2005-02-07
HUP0500345A2 (en) 2005-07-28
JP2004526401A (en) 2004-09-02
CZ20023567A3 (en) 2003-11-12
WO2001072295A2 (en) 2001-10-04
CA2404233A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003230849A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer